Evonik completes acquisition of hydrogen peroxide facility in Canada

Essen, December 1, 2011
  • A further step in Evonik's growth strategy for hydrogen peroxide (H2O2)                              

  • Production of hydrogen peroxide expanded by 44,000 metric tons per annum

 

Essen, Germany-based Evonik Industries has closed the deal to take over the hydrogen peroxide business from Kemira Chemicals Canada Inc. effective to December 1, 2011. The transaction covers the Maitland (Ontario) production plant plus the seller’s customer portfolio, with the Canadian employees also being transferred to Evonik.

"This transaction sees us taking another step in our global growth strategy for hydrogen peroxide," explained Jan Van den Bergh, Head of Advanced Intermediates, the business unit in charge of the hydrogen peroxide business at Evonik. "Our growth strategy is based on new technologies, as is exemplified by our deal in Jilin, China, where we will be supplying H2O2 to a plant specializing in the chemical direct synthesis of propylene oxide, and by targeted acquisitions like this one in Canada," added Van den Bergh. Production operations in Maitland will serve primarily to provide supplies of H2O2, an eco-friendly oxidation agent, to the North American cellulose and paper industry.

This new acquisition puts Evonik among the market leaders of hydrogen peroxide suppliers to the North American market (Canada and the U.S.). The takeover enables Evonik to increase its capacities for H2O2 production in North America by 44,000 metric tons to more than 200,000 metric tons per annum. The Group already runs local H2O2 production sites in Gibbons (Alberta, Canada) and Mobile (Alabama, U.S.A.).

Contact

Horst-Oliver Buchholz

Communications Manager Advanced Intermediates

  • Company information

    Evonik, the creative industrial group from Germany, is one of the world leaders
    in specialty chemicals. Its activities focus on the key megatrends health, nutrition, resource efficiency and globalization. In 2010 about 80 percent of the Group’s chemicals sales came from activities where it ranks among the market leaders. Evonik benefits specifically from its innovative prowess and integrated technology platforms.

    Evonik is active in over 100 countries around the world. In fiscal 2010 more than 34,000 employees generated sales of around €13.3 billion and an operating profit (EBITDA) of about €2.4 billion.

  • Disclaimer

    In so far as forecasts or expectations are expressed in this press release or where our statements concern the future, these forecasts, expectations or statements may involve known or unknown risks and uncertainties. Actual results or developments may vary, depending on changes in the operating environment. Neither Evonik Industries AG nor its group companies assume an obligation to update the forecasts, expectations or statements contained in this release.